BIOXYTRAN, INC.

BIXT ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $658.6K

Liabilities Breakdown FY2025

Total Liabilities: $3.2M